Published in J Clin Microbiol on November 01, 1988
Negligible genetic diversity of mycobacterium tuberculosis host immune system protein targets: evidence of limited selective pressure. Genetics (2000) 2.63
Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology (1994) 2.61
Heterogeneous antibody responses in tuberculosis. Infect Immun (1998) 2.54
The 14,000-molecular-weight antigen of Mycobacterium tuberculosis is related to the alpha-crystallin family of low-molecular-weight heat shock proteins. J Bacteriol (1992) 2.33
Expression of the Mycobacterium tuberculosis 19-kilodalton antigen in Mycobacterium smegmatis: immunological analysis and evidence of glycosylation. Infect Immun (1993) 2.12
Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent. J Clin Microbiol (1997) 1.69
Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG. J Clin Microbiol (2000) 1.66
Response to reactive nitrogen intermediates in Mycobacterium tuberculosis: induction of the 16-kilodalton alpha-crystallin homolog by exposure to nitric oxide donors. Infect Immun (1999) 1.65
Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice. Infect Immun (2006) 1.63
Clinical value of the measurement of Mycobacterium tuberculosis specific antibody in pulmonary tuberculosis. Thorax (1992) 1.62
Identification of mycobacterial surface proteins released into subcellular compartments of infected macrophages. Infect Immun (2000) 1.58
Use of multiepitope polyproteins in serodiagnosis of active tuberculosis. Clin Diagn Lab Immunol (2002) 1.54
Distinct H-2 complex control of mortality, and immune responses to tuberculosis infection in virgin and BCG-vaccinated mice. Clin Exp Immunol (1993) 1.52
Detection of pulmonary and extrapulmonary tuberculosis patients with the 38-kilodalton antigen from Mycobacterium tuberculosis in a rapid membrane-based assay. Clin Diagn Lab Immunol (1996) 1.50
Immunoglobulin G, A, and M responses in serum and circulating immune complexes elicited by the 16-kilodalton antigen of Mycobacterium tuberculosis. Clin Diagn Lab Immunol (2002) 1.46
Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits Mycobacterium smegmatis-induced cytokine production by human macrophages in vitro. Infect Immun (2001) 1.44
Mass spectrometric identification of mtb81, a novel serological marker for tuberculosis. J Clin Microbiol (2000) 1.44
Human humoral responses to antigens of Mycobacterium tuberculosis: immunodominance of high-molecular-mass antigens. Clin Diagn Lab Immunol (1997) 1.43
Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae. Infect Immun (1997) 1.41
Deletion of the Mycobacterium tuberculosis alpha-crystallin-like hspX gene causes increased bacterial growth in vivo. Infect Immun (2006) 1.38
Antibodies to Mycobacterium paratuberculosis-specific protein antigens in Crohn's disease. Clin Exp Immunol (1992) 1.35
Genetic influences on the immune repertoire following tuberculous infection in mice. Immunology (1990) 1.25
Levels of antibody to defined antigens of Mycobacterium tuberculosis in tuberculous meningitis. J Clin Microbiol (1989) 1.18
Antigenic and structural similarities between Mycobacterium tuberculosis 50- to 55-kilodalton and Mycobacterium bovis BCG 45- to 47-kilodalton antigens. Infect Immun (1995) 1.18
Identification of bovine T-cell epitopes for three Mycobacterium bovis antigens: MPB70, 19,000 MW and MPB57. Immunology (1994) 1.14
Characterization of B cell epitopes on the 16K antigen of Mycobacterium tuberculosis. Clin Exp Immunol (1992) 1.13
The 19-kD antigen and protective immunity in a murine model of tuberculosis. Clin Exp Immunol (2000) 1.12
Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults. Clin Diagn Lab Immunol (2003) 1.11
Adaptation to environmental stimuli within the host: two-component signal transduction systems of Mycobacterium tuberculosis. Microbiol Mol Biol Rev (2011) 1.09
Human T cell responses to peptide epitopes of the 16-kD antigen in tuberculosis. Clin Exp Immunol (1995) 1.08
Humoral immune responses against the Mycobacterium tuberculosis 38-kilodalton, MTB48, and CFP-10/ESAT-6 antigens in tuberculosis. Clin Vaccine Immunol (2010) 1.05
Analysis of a genomic DNA expression library of Mycobacterium tuberculosis using tuberculosis patient sera: evidence for modulation of host immune response. Infect Immun (1996) 1.03
Epitope-specific antibody levels demonstrate recognition of new epitopes and changes in titer but not affinity during treatment of tuberculosis. Clin Diagn Lab Immunol (2004) 1.01
Phosphate starvation enhances expression of the immunodominant 38-kilodalton protein antigen of Mycobacterium tuberculosis: demonstration by immunogold electron microscopy. Infect Immun (1992) 0.99
Evaluation of commercial enzyme-linked immunosorbent assay kits for detection of tuberculosis in Argentinean population. J Clin Microbiol (2004) 0.98
Epitope specificity and isoforms of the mycobacterial 19-kilodalton antigen. Infect Immun (1994) 0.96
Distinctive western blot antibody patterns induced by infection of mice with individual strains of the Mycobacterium avium complex. Immunology (1992) 0.92
Production of monoclonal antibody to a phenolic glycolipid of Mycobacterium tuberculosis and its use in detection of the antigen in clinical isolates. J Clin Microbiol (1992) 0.92
Recognition of peptide epitopes of the 16,000 MW antigen of Mycobacterium tuberculosis by murine T cells. Immunology (1993) 0.92
Murine and human B cell epitope mapping of the Mycobacterium tuberculosis 10-kD heat shock protein using overlapping peptides. Clin Exp Immunol (1991) 0.91
Identification, molecular cloning, and evaluation of potential use of isocitrate dehydrogenase II of Mycobacterium bovis BCG in serodiagnosis of tuberculosis. Clin Diagn Lab Immunol (2002) 0.88
Immune-complex mimics as a molecular platform for adjuvant-free vaccine delivery. PLoS One (2013) 0.84
Function and Potentials of M. tuberculosis Epitopes. Front Immunol (2014) 0.84
Lipoproteins are major targets of the polyclonal human T cell response to Mycobacterium tuberculosis. J Immunol (2012) 0.84
Diagnostic potential of fractionatedMycobacterium tuberculosis H(37)R(a) excretory-secretory (EST-DE(1)) antigen in pulmonary tuberculosis. Indian J Clin Biochem (1997) 0.83
Antibodies to Mycobacterium tuberculosis-specific epitopes in lepromatous leprosy. Clin Exp Immunol (1991) 0.82
Predominant recognition of species-specific determinants of the GroES homologues from Mycobacterium leprae and M. tuberculosis. Immunology (1998) 0.81
Anti-16-kilodalton mycobacterial protein immunoglobulin m levels in healthy but purified protein derivative-reactive children decrease after chemoprophylaxis. Clin Vaccine Immunol (2007) 0.81
Identification of RD5-encoded Mycobacterium tuberculosis proteins as B-cell antigens used for serodiagnosis of tuberculosis. Clin Dev Immunol (2012) 0.80
Epitope-specific antibody levels in tuberculosis: biomarkers of protection, disease, and response to treatment. Front Immunol (2014) 0.80
Immunochromatographic IgG/IgM test for rapid diagnosis of active tuberculosis. Clin Vaccine Immunol (2011) 0.79
Immunogenicity of the meningococcal stress protein MSP63 during natural infection. Clin Exp Immunol (1993) 0.79
Nitrotyrosine formation after activation of murine macrophages with mycobacteria and mycobacterial lipoarabinomannan. Clin Exp Immunol (1999) 0.78
Evaluation of an in-house-developed radioassay kit for antibody detection in cases of pulmonary tuberculosis and tuberculous meningitis. Clin Diagn Lab Immunol (2002) 0.75
Evaluation of an immunochromatographic test for the diagnosis of pulmonary tuberculosis in Madagascar. BMC Res Notes (2011) 0.75
Detection of Tuberculosis in HIV Co-infected Individuals: Use of Multiple ELISA Responses to 38kDa, Lipoarabinomannan and ESAT- 6 of M. tuberculosis. J Clin Diagn Res (2016) 0.75
Antigen capture ELISA for the heat shock protein (hsp60) of Chlamydia trachomatis. J Clin Pathol (1996) 0.75
Performance of a lateral flow immunochromatography test for the rapid diagnosis of active tuberculosis in a large multicentre study in areas with different clinical settings and tuberculosis exposure levels. J Thorac Dis (2016) 0.75
Proceedings of the British Thoracic Society. 12-14 July 1989, University of Southampton. Abstracts. Thorax (1989) 0.75
Identification of major glycoconjugates from Mycobacterium bovis culture filtrate by biotin-hydrazide labeling. Glycoconj J (1998) 0.75
Antigenic diversity of Mycobacterium tuberculosis and Mycobacterium bovis detected by means of monoclonal antibodies. Lancet (1981) 6.01
Characterization, sequence determination, and immunogenicity of a 64-kilodalton protein of Mycobacterium bovis BCG expressed in escherichia coli K-12. Infect Immun (1987) 6.00
Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. J Biol Chem (1986) 4.52
The serodiagnosis of tuberculosis and other mycobacterial diseases by enzyme-linked immunosorbent assay. Am Rev Respir Dis (1987) 3.67
Immunological activity of a 38-kilodalton protein purified from Mycobacterium tuberculosis. Infect Immun (1986) 3.44
The use of murine monoclonal antibodies without purification of antigen in the serodiagnosis of tuberculosis. J Immunol Methods (1982) 2.57
The humoral immune response in tuberculosis: its nature, biological role and diagnostic usefulness. Adv Tuberc Res (1984) 2.43
Evaluation of a monoclonal antibody (TB72) based serological test for tuberculosis. Clin Exp Immunol (1983) 2.12
Allergenic and blastogenic reactivity of three antigens from Mycobacterium tuberculosis in sensitized guinea pigs. Infect Immun (1987) 1.96
Universal occurrence of antibodies to tubercle bacilli in sera from non-tuberculous and tuberculous individuals. Clin Exp Immunol (1973) 1.68
Structural and immunochemical studies on D-arabino-D-mannans and D-mannans of Mycobacterium tuberculosis and other Mycobacterium species. J Biochem (1977) 1.66
Production, characterization, and species specificity of five monoclonal antibodies to Mycobacterium tuberculosis. J Clin Microbiol (1987) 1.50
Immunodiagnostic assays for tuberculosis and leprosy. Br Med Bull (1988) 1.49
Immunological activity of a 14-kilodalton recombinant protein of Mycobacterium tuberculosis H37Rv. Infect Immun (1987) 1.48
Characterization of Mycobacterium tuberculosis antigen 5 epitopes by using a panel of 19 monoclonal antibodies. J Clin Microbiol (1987) 1.24
IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science (1997) 11.89
Dissection of Mycobacterium tuberculosis antigens using recombinant DNA. Proc Natl Acad Sci U S A (1985) 7.46
Antigenic diversity of Mycobacterium tuberculosis and Mycobacterium bovis detected by means of monoclonal antibodies. Lancet (1981) 6.01
Definition of species specific and cross-reactive antigenic determinants of Mycobacterium leprae using monoclonal antibodies. Clin Exp Immunol (1983) 3.85
Differentiation of Mycobacterium tuberculosis isolates by spoligotyping and IS6110 restriction fragment length polymorphism. J Clin Microbiol (1997) 3.46
Immunological activity of a 38-kilodalton protein purified from Mycobacterium tuberculosis. Infect Immun (1986) 3.44
Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J Exp Med (1993) 2.96
Immunochemical characterization of a protein associated with Mycobacterium leprae cell wall. Infect Immun (1985) 2.88
CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex. Proc Natl Acad Sci U S A (1999) 2.81
Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today (1991) 2.71
A stationary-phase stress-response sigma factor from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1996) 2.70
IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol Cell Biol (1999) 2.68
Assessment of immunity to mycobacterial infection with luciferase reporter constructs. Infect Immun (1999) 2.65
Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology (1994) 2.61
Mycobacterium leprae-specific protein antigens defined by cloned human helper T cells. Nature (1986) 2.59
The use of murine monoclonal antibodies without purification of antigen in the serodiagnosis of tuberculosis. J Immunol Methods (1982) 2.57
Transformation of mycobacterial species using hygromycin resistance as selectable marker. Microbiology (1994) 2.55
T lymphocytes respond to solid-phase antigen: a novel approach to the molecular analysis of cellular immunity. Immunology (1986) 2.45
Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance. J Bacteriol (2000) 2.41
Tuberculosis contact investigation in low prevalence countries: a European consensus. Eur Respir J (2010) 2.38
Monoclonal antibodies to a 28,000 mol. wt protein antigen of Mycobacterium leprae. Clin Exp Immunol (1985) 2.36
The 14,000-molecular-weight antigen of Mycobacterium tuberculosis is related to the alpha-crystallin family of low-molecular-weight heat shock proteins. J Bacteriol (1992) 2.33
Characterization of antibody-reactive epitopes on the 65-kilodalton protein of Mycobacterium leprae. Infect Immun (1987) 2.30
Stress proteins may provide a link between the immune response to infection and autoimmunity. Int Immunol (1989) 2.21
Generation and characterization of monoclonal antibodies to the phenolic glycolipid of Mycobacterium leprae. Infect Immun (1984) 2.20
A serological test for leprosy with a glycolipid specific for Mycobacterium leprae. Science (1983) 2.18
Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J Virol (2000) 2.17
Expression of the Mycobacterium tuberculosis 19-kilodalton antigen in Mycobacterium smegmatis: immunological analysis and evidence of glycosylation. Infect Immun (1993) 2.12
Evaluation of a monoclonal antibody (TB72) based serological test for tuberculosis. Clin Exp Immunol (1983) 2.12
Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1999) 2.11
Mapping of T cell epitopes using recombinant antigens and synthetic peptides. EMBO J (1987) 2.09
Potential value of serology for diagnosis of extrapulmonary tuberculosis. Lancet (1990) 2.08
Biological activity of protein antigens isolated from Mycobacterium tuberculosis culture filtrate. Infect Immun (1988) 2.01
Comparison of Mycobacterium tuberculosis genomes reveals frequent deletions in a 20 kb variable region in clinical isolates. Yeast (2000) 1.96
Biochemical and antigenic characterization of the Mycobacterium tuberculosis 71kD antigen, a member of the 70kD heat-shock protein family. Mol Microbiol (1989) 1.85
Raised serum IgG and IgA antibodies to mycobacterial antigens in rheumatoid arthritis. Ann Rheum Dis (1989) 1.85
Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J Immunol (1997) 1.76
Bacterial glycoproteins: a link between glycosylation and proteolytic cleavage of a 19 kDa antigen from Mycobacterium tuberculosis. EMBO J (1996) 1.74
Screening of a recombinant mycobacterial DNA library with polyclonal antiserum and molecular weight analysis of expressed antigens. Infect Immun (1987) 1.74
Identification of a Mycobacterium tuberculosis gene that enhances mycobacterial survival in macrophages. J Bacteriol (2000) 1.73
Three pathways for trehalose biosynthesis in mycobacteria. Microbiology (2000) 1.73
Most Mycobacterium leprae carbohydrate-reactive monoclonal antibodies are directed to lipoarabinomannan. Infect Immun (1987) 1.73
Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vgamma9/Vdelta2 T lymphocytes. J Infect Dis (2001) 1.72
Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis. J Bacteriol (1998) 1.72
Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan. Biochemistry (1999) 1.70
Genetic and immunological analysis of Mycobacterium tuberculosis fibronectin-binding proteins. Infect Immun (1991) 1.69
Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent. J Clin Microbiol (1997) 1.69
Cloning and characterization of MEK6, a novel member of the mitogen-activated protein kinase kinase cascade. J Biol Chem (1996) 1.68
Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous lung disease. J Immunol (2001) 1.66
Identification of a 68-kilodalton protective protein antigen from Bordetella bronchiseptica. Infect Immun (1985) 1.66
T cell repertoire in tuberculosis: selective anergy to an immunodominant epitope of the 38-kDa antigen in patients with active disease. Eur J Immunol (1992) 1.65
A novel approach to the identification of T-cell epitopes in Mycobacterium tuberculosis using human T-lymphocyte clones. Immunology (1987) 1.63
Clinical value of the measurement of Mycobacterium tuberculosis specific antibody in pulmonary tuberculosis. Thorax (1992) 1.62
Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection. Nat Med (2001) 1.61
Vgamma9/Vdelta2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis. Eur J Immunol (2000) 1.57
A serological test for leprosy based on competitive inhibition of monoclonal antibody binding to the MY2a determinant of Mycobacterium leprae. Trans R Soc Trop Med Hyg (1983) 1.56
Paleopathological and biomolecular study of tuberculosis in a medieval skeletal collection from England. Am J Phys Anthropol (2001) 1.56
Biochemical characterization of extracellular proteases from Vibrio cholerae. Infect Immun (1982) 1.54
Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients. Int J Tuberc Lung Dis (2006) 1.53
Elevated IgG antibody levels to the mycobacterial 65-kDa heat shock protein are characteristic of patients with rheumatoid arthritis. Scand J Immunol (1989) 1.49
Influence of H-2 genes on growth of Mycobacterium tuberculosis in the lungs of chronically infected mice. Immunology (1992) 1.49
Immunodiagnostic assays for tuberculosis and leprosy. Br Med Bull (1988) 1.49
Association of tuberculosis and M. tuberculosis-specific antibody levels with HLA. J Infect Dis (1989) 1.48
Human T- and B-cell reactivity to the 16kDa alpha-crystallin protein of Mycobacterium tuberculosis. Scand J Immunol (1998) 1.47
Control by H-2 genes of murine antibody responses to protein antigens of Mycobacterium tuberculosis. Immunology (1986) 1.46
Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment. Int J Tuberc Lung Dis (2005) 1.46
Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits Mycobacterium smegmatis-induced cytokine production by human macrophages in vitro. Infect Immun (2001) 1.44
Peptide-specific T cell response to Mycobacterium tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy. J Infect Dis (1998) 1.43
Analysis of human T-cell epitopes in the 19,000 MW antigen of Mycobacterium tuberculosis: influence of HLA-DR. Immunology (1991) 1.42
Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae. Infect Immun (1997) 1.41
Evaluation of human antimycobacterial immunity using recombinant reporter mycobacteria. J Infect Dis (2000) 1.39
Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1. Gene Ther (2002) 1.36
Increase of tuberculous infection in the organs of B cell-deficient mice. Clin Exp Immunol (1996) 1.36
Influence of the TonB energy-coupling protein on efflux-mediated multidrug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1998) 1.36
Antibodies to Mycobacterium paratuberculosis-specific protein antigens in Crohn's disease. Clin Exp Immunol (1992) 1.35
Alteration of a single amino acid residue reverses fosfomycin resistance of recombinant MurA from Mycobacterium tuberculosis. Microbiology (1999) 1.33
The identification of T cell epitopes in Mycobacterium tuberculosis using human T lymphocyte clones. Lepr Rev (1986) 1.32
Genetically permissive recognition of adjacent epitopes from the 19-kDa antigen of Mycobacterium tuberculosis by human and murine T cells. J Immunol (1993) 1.32
Identification of T cell stimulatory peptides from the 38-kDa protein of Mycobacterium tuberculosis. J Immunol (1991) 1.30
Idiotypic networks and their possible exploitation for manipulation of the immune response. Lancet (1981) 1.29
Crystal structure of the anti-fungal target N-myristoyl transferase. Nat Struct Biol (1998) 1.29
A gene from Mycobacterium tuberculosis which is homologous to the DnaJ heat shock protein of E. coli. Nucleic Acids Res (1988) 1.28
Presence of human 65 kD heat shock protein (hsp) in inflamed joints and subcutaneous nodules of RA patients. Scand J Immunol (1990) 1.27
Structure of mycobacterial antigens. Br Med Bull (1988) 1.27
Surface expression by mononuclear phagocytes of an epitope shared with mycobacterial heat shock protein 60. Eur J Immunol (1991) 1.26
Genetic influences on the immune repertoire following tuberculous infection in mice. Immunology (1990) 1.25
Murine T cell-stimulatory peptides from the 19-kDa antigen of Mycobacterium tuberculosis. Epitope-restricted homology with the 28-kDa protein of Mycobacterium leprae. J Immunol (1991) 1.25
A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagents. Infect Immun (2000) 1.24
Molecular cloning and functional analysis of a novel tetracycline resistance determinant, tet(V), from Mycobacterium smegmatis. Antimicrob Agents Chemother (1998) 1.24
Specificity of proliferative response of human CD8 clones to mycobacterial antigens. Eur J Immunol (1988) 1.23
Ribosomal internal transcribed spacer sequences are identical among Mycobacterium avium-intracellulare complex isolates from AIDS patients, but vary among isolates from elderly pulmonary disease patients. Microbiology (1995) 1.23
Cell binding and internalization by filamentous phage displaying a cyclic Arg-Gly-Asp-containing peptide. J Biol Chem (1994) 1.23
Mechanisms of natural resistance to trypanosomal infection. Role of complement in avian resistance to Trypanosoma cruzi infection. Immunology (1976) 1.22
Crystallographic analysis of triclosan bound to enoyl reductase. J Mol Biol (1999) 1.20
Differential pattern of T cell recognition of the 65-kDa mycobacterial antigen following immunization with the whole protein or peptides. Eur J Immunol (1989) 1.20